Prashant Warier, Sonic AI

Skip to content

Home Discover Library Ask Sonic Projects

Use with Claude or ChatGPT

Home Discover Library Ask Sonic Projects

Use with Claude or ChatGPT

Prashant Warier, Sonic AI

Home/Library/Prashant Warier

P

Prashant Warier

Co-founder and CEO, Qure.ai · Person

13

Mentions

1

Episodes

13

Claims

Prashant Warier - Co-founder and CEO, Qure.ai. Tracked across 13 mentions in podcasts and expert conversations analyzed by Sonic.

What Prashant Warier has said

Qure.ai's tuberculosis screening algorithm is used across approximately 70 to 75 countries to screen more than 15 million patients annually.

bullish·Prashant Warier

Clinical studies have demonstrated that Qure.ai's platform can enable a lung cancer diagnosis more than 60 days earlier than standard methods.

bullish·Prashant Warier

Qure.ai employs a team of approximately 200 data scientists and engineers focused on research and development.

neutral·Prashant Warier

Qure.ai's tuberculosis screening algorithm is used across approximately 70 to 75 countries to screen more than 15 million patients annually.

Expert perspectivePrashant WarierJun 20

Clinical studies have demonstrated that Qure.ai's platform can enable a lung cancer diagnosis more than 60 days earlier than standard methods.

Expert perspectivePrashant WarierJun 20

Qure.ai employs a team of approximately 200 data scientists and engineers focused on research and development.

Expert perspectivePrashant WarierJun 20

Qure.ai has built a database of more than 1.5 billion medical images to train its AI algorithms.

Expert perspectivePrashant WarierJun 20

Qure.ai has 65 of its AI-detected findings cleared for use in Europe via CE marking.

Official sourcePrashant WarierJun 20

Qure.ai's products are cleared for use in more than 105 countries.

Expert perspectivePrashant WarierJun 20

Qure.ai has received 26 clearances from the U.S. Food and Drug Administration (FDA) for its products.

Official sourcePrashant WarierJun 20

In 2021, the World Health Organization (WHO) endorsed Qure.ai's algorithm for autonomous interpretation of chest X-rays to detect tuberculosis.

Official sourcePrashant WarierJun 20

Qure.ai is currently in the process of obtaining FDA clearance for its wrist fracture detection solution.

Expert perspectivePrashant WarierJun 20

Qure.ai's lung cancer pathway product is currently used by approximately 700 to 800 medical centers worldwide.

Expert perspectivePrashant WarierJun 20

Qure.ai began its business operations in the United States approximately 1.5 years ago.

Expert perspectivePrashant WarierJun 20

Prashant Warier predicts that AI will become the primary interface for patient care in primary care settings within the next 5 to 10 years.

SpeculativePrashant WarierJun 20

Prashant Warier predicts that Qure.ai will be deployed across most major U.S. hospital systems within the next one to two years.

SpeculativePrashant WarierJun 20

Create a free account to see Prashant Warier's full intelligence report - every claim, the relationship network, and AI Q&A across all sources. No card needed.

Get started free

Back to Entities Entity Detail